Quest Diagnostics
DGX
#1045
Rank
โ‚น2.145 T
Marketcap
โ‚น19,289
Share price
0.38%
Change (1 day)
28.76%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น786.46. In 2024 the company made an earnings per share (EPS) of โ‚น708.18 an increase over its 2023 EPS that were of โ‚น690.89.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.045.49%
2024โ‚น708.182.5%
2023โ‚น690.89-5.83%
2022โ‚น733.67-49.21%
2021โ‚น1,44549.72%
2020โ‚น964.8866.67%
2019โ‚น578.9318%
2018โ‚น490.63-4.26%
2017โ‚น512.4823.19%
2016โ‚น415.99-7.11%
2015โ‚น447.8528.46%
2014โ‚น348.63-31.61%
2013โ‚น509.7560.46%
2012โ‚น317.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น933.02 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น64.79-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น80.10-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น179.05-77.23%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.12-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA